Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesDec 29, 2011Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
S-1Registration statement for face-amount certificate companiesNov 30, 2011Open Registration statement for face-amount certificate companies in HTML.Open Registration statement for face-amount certificate companies in DOC file.Open Registration statement for face-amount certificate companies in PDF file.Open Registration statement for face-amount certificate companies in XLS file.